The pharmaceutical market is constantly evolving, with a growing demand for treatments for neurological disorders such as Parkinson's disease. Rotigotine, a key therapeutic agent, relies on a specific set of intermediates for its synthesis, with (S)-2-Amino-5-methoxytetralin Hydrochloride (CAS 58349-17-0) being a particularly crucial one. This article explores the market dynamics surrounding this intermediate, providing valuable information for R&D scientists and procurement managers.

The significance of CAS 58349-17-0 in the pharmaceutical supply chain stems directly from its role as a precursor to Rotigotine. As a non-ergot dopamine agonist, Rotigotine is prescribed to manage the motor symptoms of Parkinson's disease. The synthesis pathway requires a chiral intermediate like (S)-2-Amino-5-methoxytetralin Hydrochloride, making its availability and quality paramount. When researchers search for 'Rotigotine intermediate suppliers', they are often looking for manufacturers who can reliably produce this specific compound with high purity.

Understanding the market for CAS 58349-17-0 involves considering several factors. Firstly, global demand for Parkinson's treatments influences the volume requirements for this intermediate. Secondly, the competitive landscape of chemical manufacturing, particularly in regions like China, offers numerous options for sourcing. Buyers can 'buy (S)-2-Amino-5-methoxytetralin Hydrochloride' from a range of manufacturers, but discerning the best fit requires careful evaluation. Key considerations include production capacity, quality control measures, and price competitiveness.

Procurement managers actively look for 'competitive pricing for CAS 58349-17-0' while ensuring they are not compromising on quality. Direct engagement with manufacturers often yields better pricing and more transparency compared to sourcing through multiple distributors. Inquiring about bulk purchase discounts or establishing long-term supply agreements can further optimize procurement costs. Furthermore, it's essential to assess a manufacturer's responsiveness and their ability to meet delivery timelines, which are critical for uninterrupted API production.

In conclusion, the market for Rotigotine intermediates, particularly CAS 58349-17-0, is dynamic and crucial for the pharmaceutical industry. By staying informed about market trends, understanding quality requirements, and strategically selecting manufacturers, companies can ensure a steady and high-quality supply of this essential building block for Rotigotine synthesis.